GeneChem Inc. Receives U.S. FDA NDIN No Objection for Siallac6®, 6'-Sialyllactose Sodium Salt in Collaboration with REJIMUS, INC.
GeneChem Inc., a biotechnology company specializing in AI-powered enzyme engineering and the development of high-value biomaterials, today announced that the U....
Read disclosure →